Skip to main content
Journal cover image

Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy.

Publication ,  Journal Article
Skinner, CS; Rawl, SM; Moser, BK; Buchanan, AH; Scott, LL; Champion, VL; Schildkraut, JM; Parmigiani, G; Clark, S; Lobach, DF; Bastian, LA
Published in: J Gen Intern Med
April 2005

The Cancer Risk Intake System (CRIS), a computerized program that "matches" objective cancer risks to appropriate risk management recommendations, was designed to facilitate patient-clinician discussion. We evaluated CRIS in primary care settings via a single-group, self-report, pretest-posttest design. Participants completed baseline telephone surveys, used CRIS during clinic visits, and completed follow-up surveys 1 to 2 months postvisit. Compared with proportions reporting having had discussions at baseline, significantly greater proportions of participants reported having discussed tamoxifen, genetic counseling, and colonoscopy, as appropriate, after using CRIS. Most (79%) reported CRIS had "caused" their discussion. CRIS is an easily used, disseminable program that showed promising results in primary care settings.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Gen Intern Med

DOI

EISSN

1525-1497

Publication Date

April 2005

Volume

20

Issue

4

Start / End Page

360 / 365

Location

United States

Related Subject Headings

  • Tamoxifen
  • Risk Assessment
  • Primary Health Care
  • Physician-Patient Relations
  • Patient Education as Topic
  • Patient Acceptance of Health Care
  • Ovarian Neoplasms
  • Odds Ratio
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Skinner, C. S., Rawl, S. M., Moser, B. K., Buchanan, A. H., Scott, L. L., Champion, V. L., … Bastian, L. A. (2005). Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy. J Gen Intern Med, 20(4), 360–365. https://doi.org/10.1111/j.1525-1497.2005.40115.x
Skinner, Celette Sugg, Susan M. Rawl, Barry K. Moser, Adam H. Buchanan, Linda L. Scott, Victoria L. Champion, Joellen M. Schildkraut, et al. “Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy.J Gen Intern Med 20, no. 4 (April 2005): 360–65. https://doi.org/10.1111/j.1525-1497.2005.40115.x.
Skinner CS, Rawl SM, Moser BK, Buchanan AH, Scott LL, Champion VL, et al. Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy. J Gen Intern Med. 2005 Apr;20(4):360–5.
Skinner, Celette Sugg, et al. “Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy.J Gen Intern Med, vol. 20, no. 4, Apr. 2005, pp. 360–65. Pubmed, doi:10.1111/j.1525-1497.2005.40115.x.
Skinner CS, Rawl SM, Moser BK, Buchanan AH, Scott LL, Champion VL, Schildkraut JM, Parmigiani G, Clark S, Lobach DF, Bastian LA. Impact of the Cancer Risk Intake System on patient-clinician discussions of tamoxifen, genetic counseling, and colonoscopy. J Gen Intern Med. 2005 Apr;20(4):360–365.
Journal cover image

Published In

J Gen Intern Med

DOI

EISSN

1525-1497

Publication Date

April 2005

Volume

20

Issue

4

Start / End Page

360 / 365

Location

United States

Related Subject Headings

  • Tamoxifen
  • Risk Assessment
  • Primary Health Care
  • Physician-Patient Relations
  • Patient Education as Topic
  • Patient Acceptance of Health Care
  • Ovarian Neoplasms
  • Odds Ratio
  • Middle Aged
  • Male